Displaying drugs 12451 - 12475 of 12628 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Willardiine | 199.166 C7H9N3O4 | Willardiine is a compound isolated from seeds of Acacia willariana. | Amino Acids / Amino Acids, Peptides, and Proteins / Pyrimidines / Pyrimidinones | |
WIN 55212-2 | 426.516 C27H26N2O3 | WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical structure. It... | Agents producing tachycardia | |
WIN-54954 | 383.269 C18H20Cl2N2O3 | WIN-54954 is a broad-spectrum antipicornavirus drug. | Not Available | |
WL-1002 | Not Available | Investigated for use/treatment in osteoarthritis and pain (acute or chronic). | Not Available | |
WNT-974 | 396.454 C23H20N6O | WNT974 has been used in trials studying the treatment of Metastatic Colorectal Cancer and Squamous Cell Carcinoma, Head And Neck. | Enzyme Inhibitors | |
Wood creosote | Not Annotated | Not Annotated | Expectorants | |
Wortmannin | 428.4319 C23H24O8 | Wortmannin is a steroid metabolite of Penicillium funiculosum and Talaromyces wortmannii fungi. This drug acts as a nonspecific, covalent inhibitor of phosphoinositide 3-kinase enzymes (PI3Ks). | Androstadienes / Antifungal Agents / Immunosuppressive Agents / Insulin Antagonists / Protein Kinase Inhibitors / Radiation-Sensitizing Agents / Serotonin Receptor Antagonists | |
WP-1066 | 356.223 C17H14BrN3O | WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms. | Benzene Derivatives / Benzylidene Compounds / Heterocyclic Compounds, Fused-Ring / Nitriles / Quinoxalines | |
WP-1122 | 248.231 C10H16O7 | WP-1122 is a prodrug of 2-deoxy-D-glucose (2-DG). It was granted FDA orphan designation for the treatment of glioblastoma multiforme. | Carbohydrates / Deoxy Sugars | |
WRR-112 | 364.436 C19H28N2O5 | Not Available | Not Available | |
WRR-204 | 600.724 C34H36N2O6S | Not Available | Not Available | |
WRR-99 | 364.436 C19H28N2O5 | Not Available | Not Available | |
WSD-0922 | 442.442 C23H21F3N4O2 | Not Annotated | Not Annotated | |
WT-1 A1 | 1115.31 C55H74N10O13S | Not Annotated | Not Annotated | |
WX-UK1 | 650.28 C32H48ClN5O5S | Investigated for use/treatment in solid tumors. | Amino Acids / Amino Acids, Aromatic / Amino Acids, Cyclic / Amino Acids, Peptides, and Proteins | |
WZB-117 | 368.316 C20H13FO6 | Not Annotated | Glucose Transporter Type 1, antagonists & inhibitors | |
X-165 | Not Annotated | Not Annotated | Not Annotated | |
X-396 | 547.41 C25H25Cl2FN6O3 | X-396 has been used in trials studying the treatment of Advanced Solid Tumors and Non-small Cell Lung Cancer. | Antineoplastic Agents / Protein Kinase Inhibitors | |
Xaliproden | 381.442 C24H22F3N | Investigated for use/treatment in amyotrophic lateral sclerosis (ALS) and alzheimer's disease. | Antidepressive Agents / Central Nervous System Depressants / Nervous System / Neurotransmitter Agents / Serotonin Agents | |
Xamoterol | 339.392 C16H25N3O5 | Xamoterol is a β1-adrenoceptor partial agonist that has shown to improve systolic and diastolic function in studies with heart failure patients. It modulates the sympathetic control of the heart but... | Agents producing tachycardia / Agents that produce hypertension | |
Xanomeline | 281.42 C14H23N3OS | Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium). | Muscarinic Agonists / Parasympathomimetics | |
Xanthan gum | Not Annotated | Xanthan gum is a polysaccharide gum derived from* Xanthomonas campestris* by a pure-culture fermentation process and purified by recovery with isopropyl alcohol. The major constituents include D-glucose, D-mannose, and D-glucuronic... | Drug Carriers / Food Additives | |
Xanthine | 152.1109 C5H4N4O2 | A drug used to manage uncomplicated liver dysfunction in combination with orotic acid. | Xanthine derivatives | |
Xanthinol | 311.342 C13H21N5O4 | A vasodilatory niacin found in diet supplements. | Purine Derivatives | |
Xanthohumol | 354.3964 C21H22O5 | Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome). | Angiogenesis Inhibitors / Antineoplastic Agents |
Displaying drugs 12451 - 12475 of 12628 in total